No 10Y consistency score yet for revenue — the year-earlier revenue was zero, negative or too small a base to compare against in 32 of the 40 quarters in the window, leaving 8 comparable quarters; at least 28 are needed.
Valuation vs own 10Y history: P/S 7.6x · 10Y median 10.2x · 36th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 37
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T21:48:07.836Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T21:48:07.836Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T21:48:07.836Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T21:48:07.836Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T21:48:07.836Z. Latest historical point 2024-11-14.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T21:48:07.836Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T21:48:07.836Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T21:48:07.836Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Sigma Lithium Corporation (SGML) stock was $9.71 as of Oct 6, 2026, 4:00 PM EDT, up 1.57% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +27.5% · 3-year avg -29.9%/yr · 5-year avg +2.1%/yr
Sigma Lithium Corporation, with its corporate headquarters in São Paulo, Brazil, is dedicated to the exploration and development of lithium resources within the country. The company maintains a full 100% ownership stake in its key Brazilian properties: Grota do Cirilo, Genipapo, Santa Clara, and São José.
Industrial Materials · Toronto, ON
Next Earnings Date
Nov 13, 2026
38 days away
EPS Estimate
0.08
Revenue Est.
$40.09M
Last Quarter Results
EPS
$-0.02
vs Estimate
$0.23
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1SGML | $1.08B | $9.71 | +1.57% | +27.49% | +2.14% | N/A | N/A |
| 2CRML | $1.08B | $7.36 | -2.00% | -5.86% | N/A | N/A | vs SGML |
| 3GPRE | $1.06B | $15.16 | +0.07% | +56.66% | -15.18% | -5.26% | vs SGML |
| 4CNL | $1.13B | $12.22 | +0.91% | -8.70% | N/A | N/A | vs SGML |
| 5EMAT | $1.14B | $1.92 | -6.57% | N/A | N/A | N/A | vs SGML |
| 6NWPX | $1.02B | $105.48 | -0.11% | +101.81% | +33.95% | +24.24% | vs SGML |
forward FY estimate
N/A
$54.70M
vs Estimate
$68.34M
Consensus Rating
Based on 3 analysts
Average Price Target
$11.33
+16.7% upside
Low
$10.00
Current
$9.71
High
$13.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.03 | $0.04 | $0.05 | 1 |
| Quarter ending Dec 2026 | $0.03 | $0.03 | $0.03 | 2 |
| Quarter ending Mar 2027 | $0.12 | $0.13 | $0.14 | 1 |
| Quarter ending Jun 2027 | $0.17 | $0.18 | $0.19 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $0.26 | $0.29 | $0.32 | 1 |
| FY 2027 | $1.20 | $1.56 | $1.93 | 2 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $38.36M | $40.09M | $41.82M | 2 |
| Quarter ending Dec 2026 | $62.11M | $62.41M | $62.71M | 2 |
| Quarter ending Mar 2027 | $108.63M | $113.15M | $117.67M | 1 |
| Quarter ending Jun 2027 | $109.84M | $114.41M | $118.98M | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $197.70M | $198.52M | $199.34M | 2 |
| FY 2027 | $435.74M | $477.21M | $518.68M | 2 |
